

Publisher: Karger
E-ISSN: 1424-859x|135|1|19-24
ISSN: 1424-8581
Source: Cytogenetic and Genome Research, Vol.135, Iss.1, 2011-08, pp. : 19-24
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Management of early-onset breast cancer and BRCA1 or BRCA2 status
By Haffty B.G.
The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. :


Management of early-onset breast cancer and BRCA1 or BRCA2 status
The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. :


Does Guideline-Adherent Therapy Improve the Outcome for Early-Onset Breast Cancer Patients?
Oncology, Vol. 78, Iss. 3-4, 2010-04 ,pp. :

